UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Riverview Trust Co

Riverview Trust Co increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,121 shares of the healthcare conglomerate’s stock after acquiring an additional 33 shares during the period. Riverview Trust Co’s holdings in UnitedHealth Group were worth $567,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in UNH. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at about $37,000. Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $57,000. DecisionPoint Financial LLC raised its position in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the last quarter. Finally, FPC Investment Advisory Inc. boosted its position in UnitedHealth Group by 863.6% during the fourth quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock worth $58,000 after acquiring an additional 95 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on UNH shares. Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Piper Sandler dropped their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $474.95 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a 50-day moving average of $516.59 and a two-hundred day moving average of $557.04. The stock has a market cap of $437.09 billion, a P/E ratio of 30.64, a PEG ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.77%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.